Distigmine (ubretid).
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use*; D011183:Postoperative Complications; D014555:Urination Disorders / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics